ABC of monitoring drug therapy. Digoxin.

ABC of monitoring drug therapy. Digoxin.

Dades bibliogràfiques
Autors principals:	Aronson, J, Hardman, M
Format:	Journal article
Idioma:	English
Publicat:	1992

Ítems similars

ABC of monitoring drug therapy. Why monitor drug therapy?
per: Aronson, J, et al.
Publicat: (1992)

ABC of monitoring drug therapy. Patient compliance.
per: Aronson, J, et al.
Publicat: (1992)

ABC of monitoring drug therapy. Theophylline.
per: Aronson, J, et al.
Publicat: (1992)

ABC of monitoring drug therapy. Phenytoin.
per: Aronson, J, et al.
Publicat: (1992)

ABC of monitoring drug therapy. Measuring plasma drug concentrations.
per: Aronson, J, et al.
Publicat: (1992)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
per: Aronson, J, et al.
Publicat: (1978)

Monitoring digoxin therapy: III. How useful are the nomograms?
per: Aronson, J
Publicat: (1978)

ABC of monitoring drug therapy. Lithium.
per: Aronson, J, et al.
Publicat: (1992)

ABC of monitoring drug therapy. Cyclosporin.
per: Reynolds, D, et al.
Publicat: (1992)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
per: Aronson, J, et al.
Publicat: (1977)

ABC of monitoring drug therapy. Aminoglycoside antibiotics.
per: Aronson, J, et al.
Publicat: (1992)

Digoxin revisited.
per: Aronson, J
Publicat: (1998)

Drug therapy monitoring (TDM) of Digoxin: safety and efficacy review
per: Rony Abdi Syahputra, et al.
Publicat: (2022-04-01)

ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.
per: Reynolds, D, et al.
Publicat: (1993)

Interaction of digoxin with quinine.
per: Aronson, J, et al.
Publicat: (1981)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
per: S. F. Zadvorev, et al.
Publicat: (2018-05-01)

Clinical pharmacokinetics of digoxin 1980.
per: Aronson, J
Publicat: (1980)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
per: Aronson, J, et al.
Publicat: (1977)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
per: Ford, A, et al.
Publicat: (1979)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
per: Aronson, J, et al.
Publicat: (1983)

Indications for the measurement of plasma digoxin concentrations.
per: Aronson, J
Publicat: (1983)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
per: M Yurdakök, et al.
Publicat: (1989-10-01)

Appropriateness of digoxin level monitoring
per: MR Mordasini, et al.
Publicat: (2002-09-01)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
per: Aronson, J, et al.
Publicat: (1980)

In vivo cation transport during short-term and long-term digoxin therapy.
per: Boon, N, et al.
Publicat: (1986)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
per: Boon, N, et al.
Publicat: (1984)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
per: Ford, A, et al.
Publicat: (1979)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
per: Pugh, S, et al.
Publicat: (1982)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
per: Aronson, J, et al.
Publicat: (1982)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
per: Sophia Sheikh, et al.
Publicat: (2024-06-01)

Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods
per: Isabel Cristina Medeiros Barros, et al.
Publicat: (2014-01-01)

Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care
per: Emma M García-Iranzo, et al.
Publicat: (2017-07-01)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
per: Zeynep ÖZTÜRK, et al.
Publicat: (2018-01-01)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
per: Antonella Colella, et al.
Publicat: (2022-06-01)

Monitoring drug therapy.
per: Buclin, T, et al.
Publicat: (2012)

Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
per: Michaëlsson Karl, et al.
Publicat: (2004-04-01)

Neglected facts in digoxin intoxication
per: Sibel Ocak Serin
Publicat: (2017-06-01)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and performance of an isolated, perfused working guinea-pig heart
per: Zannad, F, et al.
Publicat: (1982)

THE EFFECTS OF DIGOXIN AND DOPAMINE ON THE OXYGEN-CONSUMPTION, LACTATE PRODUCTION AND PERFORMANCE OF AN ISOLATED, PERFUSED WORKING GUINEA-PIG HEART
per: Zannad, F, et al.
Publicat: (1982)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
per: Marcin Wais, et al.
Publicat: (2024-04-01)